News

Clínic Barcelona

Research July 6 2023

The ”la Caixa” Foundation and the Hospital Clínic Barcelona renew their cancer research alliance

The ”la Caixa” Foundation will allocate 4.6 million euros to promoting research at the Hospital Clínic Barcelona, in order to develop new, personaliz1

Clínic Barcelona

Research July 4 2023

The CAR T-cell therapy from the Hospital Clínic-IDIBAPS for multiple myeloma is effective in patients with refractory disease

A multicentre study led by the Hospital Clínic Barcelona-IDIBAPS demonstrates the efficacy of the CAR T-cell therapy ARI0002h in treating patients wi1

Clínic Barcelona

Research January 19 2023

Isabel Blanco, Carlos Fernández de Larrea and Gisela Sugranyes: new senior group leaders (R4) of IDIBAPS

IDIBAPS’s Board of Governors has approved the promotion of Isabel Blanco, Carlos Fernández de Larrea and Gisela Sugranyes from Junior Group Leaders t1

Clínic Barcelona

Institutional July 22 2022

Representatives of the Spanish Association Against Cancer visit IDIBAPS

The activity, which is part of a new communication project, allowed visitors to learn about the cancer research carried out by the Institute's resear1

Clínic Barcelona

Research June 16 2022

EMERALD, the first European-wide PhD program for medical doctors, opens 2nd call for applications

The deadline for applications is the 28th August and 2 of the 15 fellows will be hired by IDIBAPS.

2 3

page1
page2 , current page.
page3

News

The ”la Caixa” Foundation and the Hospital Clínic Barcelona renew their cancer research alliance

The CAR T-cell therapy from the Hospital Clínic-IDIBAPS for multiple myeloma is effective in patients with refractory disease

Isabel Blanco, Carlos Fernández de Larrea and Gisela Sugranyes: new senior group leaders (R4) of IDIBAPS

Representatives of the Spanish Association Against Cancer visit IDIBAPS

EMERALD, the first European-wide PhD program for medical doctors, opens 2nd call for applications

navigation between pages below